Precision reprogramming iPSCs to generate a source of defined, scalable human cells

See how bit.bio's platform uses opti-ox technology to consistently convert stem cells into defined human cells. The resulting cells enable scalable disease research and drug discovery, with time and cost improvements over traditional technologies.